Ledger.Open graph →
SEC Form D · filed March 24, 2021

Monte Rosa Therapeutics, Inc

Offering
$95.0M
Sold
$95.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Alexander Mayweg · Boston, MADirectorMarkus Warmuth · Boston, MAExec · DirectorBradley Bolzon · Boston, MADirectorKim Blackwell · Boston, MADirectorAli Behbahani · Boston, MADirectorDrew Schiff · Boston, MADirectorNicole Quinn · Carlsbad, CADirectorLauren Otsuki · Carlsbad, CAExec · DirectorTodd Jackson · Carlsbad, CADirectorJordan Albert · Los Angeles, CADirectorCarol Shen · Carlsbad, CADirectorChandra P. Leo · Boston, MADirectorChristine P. Siu · Boston, MADirectorAjim P. Tamboli · Boston, MAExecRonald Geraty · Marblehead, MADirectorJustin Ort · New York, NYDirectorC/O Aztec Financial Cgr Iv GP S.A.R.L · SENNINGERBERG, LuxembourgExec · DirectorChad Gordon · Cockeysville, MDDirectorJoshua I. Scheinker · Lutherville, MDDirectorDrew Schiff · Boston, MADirectorChandra P. Leo · Boston, MADirectorChristine P. Siu · Boston, MADirectorAjim P. Tamboli · Boston, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗